4月25日 - ** Verastem Oncology公司VSTM.O股价早盘上涨4.8%，至7.86美元
** 癌症药物开发商宣布在投资公司RTW的主导下，进行7,500万美元的私募配售（(link)
** 该公司已与投资者达成协议，配售 2400 万美元的股票和 5100 万美元的预融资认股权证
** 古根海姆证券公司是此次私募的牵头机构
** 募集资金将用于可能推出的实验性癌症疗法avutometinib 及其他用途
** 截至上一交易日收盘，VSTM 股价年累计上涨 45
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.